Capital Expenditures - Syneos Health Inc (F:8IN) - Alpha Spread
S

Syneos Health Inc
F:8IN

Watchlist Manager
Syneos Health Inc
F:8IN
Watchlist
Price: 40 EUR Market Closed
Market Cap: 4.1B EUR
Have any thoughts about
Syneos Health Inc?
Write Note

Syneos Health Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Syneos Health Inc
Capital Expenditures Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
S
Syneos Health Inc
F:8IN
Capital Expenditures
-$91m
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Capital Expenditures
-$1.4B
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
-15%
Danaher Corp
NYSE:DHR
Capital Expenditures
-$1.3B
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
-9%
Mettler-Toledo International Inc
NYSE:MTD
Capital Expenditures
-$94.6m
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Capital Expenditures
-$369m
CAGR 3-Years
-34%
CAGR 5-Years
-18%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Capital Expenditures
-$613m
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-25%

See Also

What is Syneos Health Inc's Capital Expenditures?
Capital Expenditures
-91m USD

Based on the financial report for Jun 30, 2023, Syneos Health Inc's Capital Expenditures amounts to -91m USD.

What is Syneos Health Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-9%

Over the last year, the Capital Expenditures growth was -10%. The average annual Capital Expenditures growth rates for Syneos Health Inc have been -11% over the past three years , -9% over the past five years .

Back to Top